TCM
AVNS

Teza Capital Management’s Avanos Medical AVNS Stock Holding History

Teza Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-7,773
Closed -$228K – 378
2020
Q2 		$228K Buy
+7,773
New +$225K 0.05% 460

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Teza Capital Management's AVNS Position: Q3 2020 in Review

Teza Capital Management sold out of Avanos Medical (AVNS) in Q3 2020, closing a stake of 7,773 shares — an estimated $228K sold.

Teza Capital Management first reported a position in AVNS in Q2 2020 and held it in 1 quarter. The position peaked at $228K in Q2 2020. 272 funds tracked by Wall St. Rank hold AVNS as of Q3 2020.

  • Teza Capital Management reported no remaining Avanos Medical position as of Q3 2020 after selling out during the quarter.
  • Teza Capital Management sold 7,773 Avanos Medical shares in Q3 2020, an estimated $228K.
  • Teza Capital Management first reported a position in Avanos Medical in Q2 2020 and held it in 1 quarter.
  • Teza Capital Management's Avanos Medical position peaked at $228K in Q2 2020.
  • 272 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2020.

Based on Teza Capital Management's 13F filing for Q3 2020, filed 12 Nov 2020.